Cargando…

Quantitative analysis of contrast enhanced spectral mammography grey value for early prediction of pathological response of breast cancer to neoadjuvant chemotherapy

A quantitative analysis of contrast-enhanced spectral mammography (CESM) enhancement was conducted for the early prediction of the pathological response after neoadjuvant chemotherapy (NAC). Retrospective analysis of the data of 111 patients was conducted, and all of them underwent NAC in our hospit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, Dong, Mao, Ning, Dong, Jianjun, Ma, Heng, Chen, Qianqian, Lv, Yongbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960703/ https://www.ncbi.nlm.nih.gov/pubmed/33723322 http://dx.doi.org/10.1038/s41598-021-85353-9

Ejemplares similares

Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers
por: Wang, Zhongyi, et al.
Publicado: (2021)

Radiomics of contrast-enhanced spectral mammography for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer
por: Zhang, Kun, et al.
Publicado: (2023)

Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions
por: Xing, Dong, et al.
Publicado: (2019)

Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study
por: Yu, Liangliang, et al.
Publicado: (2020)

Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer
por: Steinhof-Radwańska, Katarzyna, et al.
Publicado: (2021)

Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging
por: Iotti, Valentina, et al.
Publicado: (2017)

Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer
por: Canteros, Daniel, et al.
Publicado: (2022)

Quantitative Analysis of Enhancement Intensity and Patterns on Contrast-enhanced Spectral Mammography
por: Liu, Ying, et al.
Publicado: (2020)

Predicting the response to neoadjuvant chemotherapy. Can the addition of tomosynthesis improve the accuracy of contrast-enhanced spectral mammography? A comparison with breast MRI
por: Savaridas, Sarah L, et al.
Publicado: (2023)

Contrast-Enhanced Spectral Mammography-Based Prediction of Non-Sentinel Lymph Node Metastasis and Axillary Tumor Burden in Patients With Breast Cancer
por: Wu, Xiaoqian, et al.
Publicado: (2022)

Contrast-Enhanced Spectral Mammography: Comparison with Conventional Mammography and Histopathology in 152 Women
por: Luczyńska, Elzbieta, et al.
Publicado: (2014)

Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer: a feasibility study
por: Barra, Filipe Ramos, et al.
Publicado: (2017)

Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology—preliminary results
por: Rudnicki, Wojciech, et al.
Publicado: (2019)

Contrast-Enhanced Spectral Mammography Versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts
por: Lu, Zhongfei, et al.
Publicado: (2020)

Comparison between Breast MRI and Contrast-Enhanced Spectral Mammography
por: Łuczyńska, Elżbieta, et al.
Publicado: (2015)

Contrast-enhanced spectral mammography with a compact synchrotron source
por: Heck, Lisa, et al.
Publicado: (2019)

Background enhancement in contrast-enhanced spectral mammography (CESM): are there qualitative and quantitative differences between imaging systems?
por: Wessling, Daniel, et al.
Publicado: (2022)

Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for Identifying Benign and Malignant Breast Lesions of Sub-1 cm
por: Lin, Fan, et al.
Publicado: (2020)

Quantitative Breast Density in Contrast-Enhanced Mammography
por: Gennaro, Gisella, et al.
Publicado: (2021)

Contrast-Enhanced Spectral Mammography: Importance of the Assessment of Breast Tumor Size
por: Nicosia, Luca, et al.
Publicado: (2021)

Accuracy and Reproducibility of Contrast-Enhanced Mammography in the Assessment of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients with Calcifications in the Tumor Bed
por: Iotti, Valentina, et al.
Publicado: (2021)

The effectiveness of contrast-enhanced spectral mammography and magnetic resonance imaging in dense breasts
por: Rudnicki, Wojciech, et al.
Publicado: (2021)

Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?
por: Liew, Amanda Ling Fung, et al.
Publicado: (2022)

Contrast-Enhanced Spectral Mammography in the Evaluation of Breast Microcalcifications: Controversies and Diagnostic Management
por: Nicosia, Luca, et al.
Publicado: (2023)

Diagnostic Value of Radiomics Analysis in Contrast-Enhanced Spectral Mammography for Identifying Triple-Negative Breast Cancer
por: Zhang, Yongxia, et al.
Publicado: (2021)

Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results
por: Łuczyńska, Elżbieta, et al.
Publicado: (2016)

Retrospective Comparison of Contrast-Enhanced Spectral Mammography with Digital Mammography in Assessing Tumor Size in 668 Cases of Breast Cancer
por: Lorek, Andrzej, et al.
Publicado: (2020)

Initial outcome of contrast-enhanced spectral mammography in lesion characterisation in the mammographically dense breast
por: Hussain, Zeiad, et al.
Publicado: (2015)

Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome
por: La Forgia, Daniele, et al.
Publicado: (2020)

Contrast-enhanced spectral mammography: are kinetic patterns useful for differential diagnoses of enhanced lesions?
por: Rong, Xiaocui, et al.
Publicado: (2023)

Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI)
por: Barra, Filipe Ramos, et al.
Publicado: (2018)

The Quality of Tumor Size Assessment by Contrast-Enhanced Spectral Mammography and the Benefit of Additional Breast MRI
por: Lobbes, Marc B.I., et al.
Publicado: (2015)

Fully Automated Support System for Diagnosis of Breast Cancer in Contrast-Enhanced Spectral Mammography Images
por: Fanizzi, Annarita, et al.
Publicado: (2019)

Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review
por: Zanardo, Moreno, et al.
Publicado: (2019)

Contrast‐enhanced spectral mammography: A potential exclusion diagnosis modality in dense breast patients
por: Qin, Yun, et al.
Publicado: (2020)

A meta‐analysis of contrast‐enhanced spectral mammography versus MRI in the diagnosis of breast cancer
por: Xiang, Wanqing, et al.
Publicado: (2020)

Radiomic Feature Reduction Approach to Predict Breast Cancer by Contrast-Enhanced Spectral Mammography Images
por: Massafra, Raffaella, et al.
Publicado: (2021)

Contrast-enhanced spectral mammography (CESM)-guided breast biopsy as an alternative to MRI-guided biopsy
por: James, Jonathan
Publicado: (2022)

Comparison of Contrast-Enhanced Spectral Mammography and Contrast-Enhanced MRI in Screening Multifocal and Multicentric Lesions in Breast Cancer Patients
por: Feng, Lei, et al.
Publicado: (2022)

Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor
por: An, Yeong Yi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4ve4v021gguet3kniirthotbp4